# Gitelman syndrome in a pediatric patient: a case report and literature review

## TL;DR

A child with Gitelman syndrome had hypokalemia caused by rare SLC12A3 gene mutations, highlighting the need for early diagnosis in pediatric patients.

## Contribution

Identification of rare compound heterozygous SLC12A3 mutations in a Chinese pediatric patient with Gitelman syndrome.

## Key findings

- Compound heterozygous mutations in the SLC12A3 gene were identified as the cause of hypokalemia and growth impairment.
- The co-occurrence of p.T60M and p.T649M mutations is extremely rare in China.
- Early genetic testing is crucial for diagnosing Gitelman syndrome and improving patient outcomes.

## Abstract

This article aimed to explore the clinical presentation, genetic underpinnings, and therapeutic approach to Gitelman syndrome (GS) in pediatric patients.

This article presents a detailed case report of a child with persistent hypokalemia, incorporating clinical evaluations, laboratory testing, treatment strategy, and whole-exome sequencing. A literature review was conducted to contextualize the findings.

The patient was found to carry compound heterozygous mutations in the SLC12A3 gene, with each inherited from a different parent. These mutations were identified as the primary cause of the child's refractory hypokalemia and impaired growth.

Hypokalemia is a hallmark manifestation of pediatric GS. Genetic testing is instrumental for accurate diagnosis and differentiation from other hypokalemic conditions. The non-specific clinical phenotype of GS can lead to a missed or delayed diagnosis. In addition, co-occurrence of the p.T60M and p.T649M mutations is extremely rare in China. The presentation of this case underscores the need for heightened awareness of GS among pediatricians to enable early diagnosis and therapy, thereby optimizing the long-term quality of life of affected children.